ADHD drugs - Doorway to heart diseases

ADHD (Attention Deficit Hyperactivity Disorder) medicines will soon have their labels changed for Dexedrine, an amphetamine, used to treat ADHD and narcolepsy, so that people could be foretold about the increased possibilty of the heart problems which may occur by consumption of these drugs as announced by The Food and Drug Administration on Monday(Washington).

Earlier in March, FDA's announcement of adding the warning label was objected to by the outsider experts who were of the opinion that adding a "Black Label" would scare the the parents and the patients. The labeling has been made mandatory now.

ADHD drugs are mostly given in larger amount than needed, sometimes as much as three times more the prescribed amount, to children and adults which in turn has been found to cause heart problems and ultimately in sudden deaths.

Adderll XR (Amphetamine-Dextroamphetamine) and Retalin (Methylphenidate) are the two commonly prescribed drugs to treat symptoms of ADHD in children and adults.

GlaxoSmithKline, leading name in manufacturing of Dexedrine, advised health care professionals of changes to the drug's labeling. The company has warned that there have been reports of sudden deaths, strokes and myocaridal infraction amongst the adults who have been taking USUAL DOSES of stimulant drugs. The effects of more than usual dosage of the drug can be devastating.

Many additional psychological symptoms like hallucinations, delusional thinking, hypertension may develop and their could be enhancement in pre-psychotic disorder like bipolar disorder.